Skip to main content

Table 3 Stratified analysis of treatment modalities associated with stage I-IIA patients’ survival

From: The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

Parametres RT (−) RT (+) HR P
No. MST(mo) No. MST(mo)   
LNM (−) 34 80 12 39 3.363(1.245–10.619) 0.018
LNM (+) 15 43 7 47 0.581(0.157–2.157) 0.571
DOI (≤2/3) 9 25 6 35 0.486(0.087–2.706) 0.410
DOI (> 2/3) 40 71 13 43 2.338(0.906–6.035) 0.079
≤4 cm 28 76 10 39 0.371(0.115–1.195) 0.097
> 4 cm 21 59 9 44 1.363(0.464–4.139) 0.560
LVSI(−) 34 75 10 46 1.727(0.524–5.699) 0.369
LVSI(+) 15 51 9 36 1.385 (0.464–4.139) 0.560
  NACT(−)   NACT(+)   
> 4 cm 12 46 18 60 0.753(0.261–2.174) 0.600